These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9851801

  • 21. Placental urocortin-2 and -3: endocrine or paracrine functioning during healthy pregnancy?
    Pepels PP, Spaanderman ME, Hermus AR, Lotgering FK, Sweep CG.
    Placenta; 2010 Jun; 31(6):475-81. PubMed ID: 20451246
    [Abstract] [Full Text] [Related]

  • 22. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides.
    Margioris AN, Grino M, Protos P, Gold PW, Chrousos GP.
    J Clin Endocrinol Metab; 1988 May; 66(5):922-6. PubMed ID: 2834412
    [Abstract] [Full Text] [Related]

  • 23. Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.
    Torpy DJ, Webster EL, Zachman EK, Aguilera G, Chrousos GP.
    Neuroimmunomodulation; 1999 May; 6(3):182-6. PubMed ID: 10213916
    [Abstract] [Full Text] [Related]

  • 24. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
    Heldwein KA, Redick DL, Rittenberg MB, Claycomb WC, Stenzel-Poore MP.
    Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
    [Abstract] [Full Text] [Related]

  • 25. Involvement of CRH receptors in urocortin-induced hyperthermia.
    Telegdy G, Adamik A.
    Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757
    [Abstract] [Full Text] [Related]

  • 26. Suppression of food intake induced by corticotropin-releasing factor family in neonatal chicks.
    Zhang R, Nakanishi T, Ohgushi A, Ando R, Yoshimatsu T, Denbow DM, Furuse M.
    Eur J Pharmacol; 2001 Sep 07; 427(1):37-41. PubMed ID: 11553361
    [Abstract] [Full Text] [Related]

  • 27. Actions of magnesium, nifedipine and clonidine on the fetal vasculature of the human placenta.
    David R, Leitch IM, Read MA, Boura AL, Walters WA.
    Aust N Z J Obstet Gynaecol; 1996 Aug 07; 36(3):267-71. PubMed ID: 8883748
    [Abstract] [Full Text] [Related]

  • 28. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors.
    Suda T, Kageyama K, Sakihara S, Nigawara T.
    Peptides; 2004 Oct 07; 25(10):1689-701. PubMed ID: 15476936
    [Abstract] [Full Text] [Related]

  • 29. The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.
    Davidson SM, Rybka AE, Townsend PA.
    Biochem Pharmacol; 2009 Jan 15; 77(2):141-50. PubMed ID: 18817752
    [Abstract] [Full Text] [Related]

  • 30. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
    Florio P, Torricelli M, De Falco G, Leucci E, Giovannelli A, Gazzolo D, Severi FM, Bagnoli F, Leoncini L, Linton EA, Petraglia F.
    J Hypertens; 2006 Sep 15; 24(9):1831-40. PubMed ID: 16915033
    [Abstract] [Full Text] [Related]

  • 31. Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts.
    García-Villalón AL, Amezquita YM, Monge L, Fernández N, Climent B, Sánchez A, Diéguez G.
    Br J Pharmacol; 2005 Jun 15; 145(4):490-4. PubMed ID: 15806110
    [Abstract] [Full Text] [Related]

  • 32. Urotensin I-CRF-Urocortins: a mermaid's tail.
    Pittman QJ, Hollenberg MD.
    Gen Comp Endocrinol; 2009 Oct 15; 164(1):7-14. PubMed ID: 19409389
    [Abstract] [Full Text] [Related]

  • 33. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC.
    J Pharmacol Exp Ther; 1999 Mar 15; 288(3):1349-56. PubMed ID: 10027877
    [Abstract] [Full Text] [Related]

  • 34. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstrictor responses by a vasodilator peptide, urotensin I: comparison with nifedipine.
    Bolt GR, Itoh H, Lederis K, MacCannell KL.
    J Pharmacol Exp Ther; 1989 Dec 15; 251(3):1147-54. PubMed ID: 2574741
    [Abstract] [Full Text] [Related]

  • 35. Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition.
    Voltolini C, Battersby S, Novembri R, Torricelli M, Severi FM, Petraglia F, Norman JE.
    Endocrinology; 2015 Feb 15; 156(2):670-9. PubMed ID: 25426872
    [Abstract] [Full Text] [Related]

  • 36. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.
    Barker DM, Corder R.
    Br J Pharmacol; 1999 Jan 15; 126(1):317-25. PubMed ID: 10051151
    [Abstract] [Full Text] [Related]

  • 37. Expression of urocortin and corticotrophin-releasing hormone receptor-2 in patients with intrahepatic cholestasis of pregnancy.
    Zhou F, Zhang L, Sun Q, Wang XD.
    Placenta; 2014 Nov 15; 35(11):962-8. PubMed ID: 25172671
    [Abstract] [Full Text] [Related]

  • 38. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies.
    Rominger DH, Rominger CM, Fitzgerald LW, Grzanna R, Largent BL, Zaczek R.
    J Pharmacol Exp Ther; 1998 Jul 15; 286(1):459-68. PubMed ID: 9655891
    [Abstract] [Full Text] [Related]

  • 39. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
    Schilling L, Kanzler C, Schmiedek P, Ehrenreich H.
    Br J Pharmacol; 1998 Nov 15; 125(6):1164-71. PubMed ID: 9863643
    [Abstract] [Full Text] [Related]

  • 40. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C.
    Nature; 1995 Nov 16; 378(6554):287-92. PubMed ID: 7477349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.